First Time Loading...
C

CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765

Watchlist Manager
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Watchlist
Price: 34.27 CNY 1.63% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
CSPC Innovation Pharmaceutical Co Ltd

Wall Street analysts forecast CSPC Innovation Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CSPC Innovation Pharmaceutical Co Ltd is 41.8 CNY with a low forecast of 38.84 CNY and a high forecast of 45.68 CNY.

Lowest Forecast
Wall Street Target
38.84 CNY
13% Upside
Average Forecast
Wall Street Target
41.8 CNY
22% Upside
Highest Forecast
Wall Street Target
45.68 CNY
33% Upside
Lowest
Price Target
38.84 CNY
13% Upside
Average
Price Target
41.8 CNY
22% Upside
Highest
Price Target
45.68 CNY
33% Upside
CSPC Innovation Pharmaceutical Co Ltd Competitors:
Price Targets
H
000908
Hunan Jingfeng Pharmaceutical Co Ltd
640% Upside
WVE
WAVE Life Sciences Ltd
116% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
F
FAE
Faes Farma SA
15% Upside
H
000908
Hunan Jingfeng Pharmaceutical Co Ltd
640% Upside
WVE
WAVE Life Sciences Ltd
116% Upside
KLBF
Kalbe Farma Tbk PT
21% Upside
F
FAE
Faes Farma SA
15% Upside
INDOCO
Indoco Remedies Ltd
16% Upside
R
000650
Renhe Pharmacy Co Ltd
104% Upside
002020
Zhejiang Jingxin Pharmaceutical Co Ltd
12% Upside
ALKEM
Alkem Laboratories Ltd
1% Upside

Revenue
Forecast

Revenue Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 32%.

16%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 50%.

21%
Past Growth
50%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CSPC Innovation Pharmaceutical Co Ltd

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 31%.

25%
Past Growth
31%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CSPC Innovation Pharmaceutical Co Ltd's stock price target?
Price Target
41.8 CNY

According to Wall Street analysts, the average 1-year price target for CSPC Innovation Pharmaceutical Co Ltd is 41.8 CNY with a low forecast of 38.84 CNY and a high forecast of 45.68 CNY.

What is CSPC Innovation Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
32%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 32%.

What is CSPC Innovation Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
50%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's operating income is 21%. The projected CAGR for the next 3 years is 50%.

What is CSPC Innovation Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
31%

For the last 6 years the compound annual growth rate for CSPC Innovation Pharmaceutical Co Ltd's net income is 25%. The projected CAGR for the next 3 years is 31%.

ALPHA SPREAD
Join more than 134,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.